Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 3 Νοεμβρίου 2021, 07:35:17
-
Apixaban vs. Warfarin in Patients with Thrombotic Antiphospholipid Antibody Syndrome
Brady L. Stein, MD, MHS, reviewing Woller SC et al. Blood Adv 2021 Oct 18
Patients treated with apixaban were more likely to experience arterial thrombosis than those treated with warfarin.
https://www.jwatch.org/na54241/2021/10/29/apixaban-vs-warfarin-patients-with-thrombotic?query=etoc_jwgenmed&jwd=000100032085&jspc=GP (https://www.jwatch.org/na54241/2021/10/29/apixaban-vs-warfarin-patients-with-thrombotic?query=etoc_jwgenmed&jwd=000100032085&jspc=GP)